The worldwide supply of antiparasitic drugs appears to be dwindling because markets where the drugs most commonly are used are not economically viable, according to researchers who spoke at the recent American Society of Tropical Medicine and Hygiene meeting in Houston.
"Parasites are a very common cause of disease in the world, but because there is no market for antiparasitic drugs, drug companies are discontinuing production," said A. Clayton White, Jr, MD, of Baylor College of Medicine in Houston. White's "no market" reference means that parasitic diseases occur most often in developing countries that cannot afford to support production of the drugs.
Voelker R. Drugs in Short Supply. JAMA. 2000;284(22):2863. doi:10.1001/jama.284.22.2863